1,1-Bis(3 ′ -indolyl)-1-( p -bromophenyl)methane and Related Compounds Repress Survivin and Decrease γ -Radiation-Induced Survivin in Colon and Pancreatic Cancer Cells
暂无分享,去创建一个
S. Safe | I. Jutooru | Sandeep Sreevalsan | G. Chadalapaka | M. Walker | Gayathri Chadalapaka | Indira Jutooru
[1] S. Safe,et al. Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.
[2] S. Safe,et al. Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p-substituted phenyl)methanes , 2008, Molecular Cancer Therapeutics.
[3] S. Safe,et al. Curcumin decreases specificity protein expression in bladder cancer cells. , 2008, Cancer research.
[4] M. Abdelrahim,et al. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase. , 2008, Carcinogenesis.
[5] Fengzhi Li,et al. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. , 2008, Carcinogenesis.
[6] S. Safe,et al. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways , 2008, Breast Cancer Research and Treatment.
[7] Y. Lotan,et al. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. , 2007, Urology.
[8] J. Cleveland,et al. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. , 2007, Cancer research.
[9] N. Tsuji,et al. Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer* , 2007, Journal of Biological Chemistry.
[10] W. Mann,et al. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. , 2007, Cancer research.
[11] N. Zaffaroni,et al. Targeting survivin in cancer therapy: fulfilled promises and open questions. , 2007, Carcinogenesis.
[12] R. Walker,et al. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients , 2007, British Journal of Cancer.
[13] S. Pradhan,et al. Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells* , 2007, Journal of Biological Chemistry.
[14] B. Aggarwal,et al. γ-Tocotrienol Inhibits Nuclear Factor-κB Signaling Pathway through Inhibition of Receptor-interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of Apoptosis* , 2007, Journal of Biological Chemistry.
[15] Y. Lotan,et al. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. , 2006, Cancer.
[16] D. Altieri. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. , 2006, Current opinion in cell biology.
[17] R. Medema,et al. The case for Survivin as mitotic regulator. , 2006, Current opinion in cell biology.
[18] Lily Yang,et al. KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia* , 2006, Journal of Biological Chemistry.
[19] J. Uddin,et al. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo , 2006, Molecular Cancer.
[20] Sudhakar Chintharlapalli,et al. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARγ-dependent and PPARγ-independent pathways , 2006, Molecular Cancer Therapeutics.
[21] Zhiwei Wang,et al. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. , 2006, Cancer research.
[22] M. Abdelrahim,et al. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists. , 2006, Cancer research.
[23] Mutsushi Yamasaki,et al. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells. , 2005, Oncology reports.
[24] A. Wickrema,et al. Differential requirements for survivin in hematopoietic cell development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Hatano,et al. Transcriptional activation of survivin through the NF‐κB pathway by human T‐cell leukemia virus type I tax , 2005, International journal of cancer.
[26] K. Yoon,et al. Activation of Nur77 by Selected 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes Induces Apoptosis through Nuclear Pathways* , 2005, Journal of Biological Chemistry.
[27] C. Rödel,et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. , 2005, Cancer research.
[28] A. Chakravarti,et al. Survivin mediates resistance to antiandrogen therapy in prostate cancer , 2005, Oncogene.
[29] N. Zaffaroni,et al. Survivin as a target for new anticancer interventions , 2005, Journal of cellular and molecular medicine.
[30] Fengzhi Li,et al. Molecular Mechanism of Inhibition of Survivin Transcription by the GC-rich Sequence-selective DNA Binding Antitumor Agent, Hedamycin , 2005, Journal of Biological Chemistry.
[31] Fengzhi Li,et al. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines , 2005, Oncogene.
[32] Fengzhi Li,et al. Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest* , 2004, Journal of Biological Chemistry.
[33] A. Winoto,et al. Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis , 2004, The Journal of experimental medicine.
[34] Lily Yang,et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. , 2003, Cancer research.
[35] S. Chiou,et al. Survivin expression in the stomach: implications for mucosal integrity and protection. , 2003, Biochemical and biophysical research communications.
[36] Zvi Fuks,et al. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.
[37] C. Rödel,et al. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. , 2003, International journal of radiation oncology, biology, physics.
[38] K. Shiraki,et al. Expression of survivin during liver regeneration. , 2002, Biochemical and biophysical research communications.
[39] M. Daidone,et al. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer , 2002, Cellular and Molecular Life Sciences CMLS.
[40] Naoki Watanabe,et al. Survivin as a Radioresistance Factor in Pancreatic Cancer , 2000, Japanese journal of cancer research : Gann.
[41] F. Sigaux,et al. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia , 2000, British journal of haematology.
[42] J Diebold,et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. , 2000, Blood.
[43] D. Altieri,et al. Transcriptional analysis of human survivin gene expression. , 1999, The Biochemical journal.
[44] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.